A patient has received a first-of-its-kind treatment aimed at reversing human aging. The treatment, which involves making cells young again, is considered experimental and high-risk. The therapy is being trialled to address age-related issues, possibly including sight loss, although the specific goals and outcomes of the treatment are not yet clear.